ITI-333

· Intra-Cellular Therapies, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ITI-333, covering 2025-09-10 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers [Phase 1]

See pricing